ArticleBMC medicine2025

Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for untreated advanced or metastatic pancreatic ductal adenocarcinoma.

Qiang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.